Effects of dietary fat structure on short term changes in blood lipids and insulin sensitivity

ISRCTN ISRCTN20774126
DOI https://doi.org/10.1186/ISRCTN20774126
Secondary identifying numbers N/A
Submission date
26/02/2009
Registration date
13/03/2009
Last edited
07/02/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Tom Sanders
Scientific

Nutritional Sciences Division
Franklin Wilkins Building
150 Stamford Street
London
SE1 9NH
United Kingdom

Study information

Study designRandomised cross-over design trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe acute effects of triacylglycerol structure of palmitic acid rich fats on postprandial changes in lipid and glucose metabolism: a randomised cross-over trial
Study acronymIPART
Study objectivesChanging the triacylglycerol structure of palm oil by interesterification, to produce a fat with a high proportion of palmitic acid in the sn-2 position, will alter postprandial lipid and glucose metabolism. Postprandial responses to plant (interesterified palm oil) and animal (lard) fats with a high proportion of palmitic acid in the sn-2 position will be similar.
Ethics approval(s)West Kent Research Ethics Committee gave approval on the 14th January 2009 (ref: 08/H1101/122)
Health condition(s) or problem(s) studiedDiet and cardiovascular disease
InterventionIn a single test meal consisting of a muffin and a milkshake, three test fats (50 g) are compared versus a control fat (high oleic sunflower oil; 50 g). These are; native palm olein , chemically interesterified palm olein and lard.
1. Palm olein represents a palmitic acid-rich fat with palmitic acid almost exclusively (~90%) in the sn-1 and -3 positions
2. Chemically interesterified palm olein represents a palmitic acid-rich fat with a high proportion of palmitic acid in the sn-2 position (~33%)
3. Lard represents an animal fat with a high proportion of palmitic acid in the sn-2 position (~58%)
4. High oleic sunflower oil will be used as a reference oil for the control test meal

Contact details for joint Principal Investigator:
Professor Ronald P. Mensink, PhD
Department of Human Biology
School for Nutrition, Toxicology and Metabolism
Maastricht University
PO Box 616
6200 MD Maastricht
The Netherlands
Intervention typeOther
Primary outcome measurePostprandial changes in plasma glucose (measured at: 0, 15, 30, 60, 90, 120, 150, 180, 240, 300, 360, 420 and 480 minutes) and plasma triacylglycerol concentrations (measured at 0, 60, 120, 180, 240, 300, 360, 420 and 480 minutes). Both will be measured using enzymatic assays.
Secondary outcome measures1. Apolipoprotein B48 concentrations, measured at 0, 180, 240, 300 and 480 minutes
2. The positional distribution of chylomicron lipids in the sn-2 position, measured at 180, 240 and 300 minutes
3. Non-esterified fatty acids, measured at 0, 60, 120, 180, 240, 300, 360, 420 and 480 minutes
4. Plasma fatty acids, measured at 0, 60, 120, 180, 240, 300, 360, 420 and 480 minutes
5. Total cholesterol, measured at 0, 60, 120, 180, 240, 300, 360, 420 and 480 minutes
6. Insulin, measured at 0, 15, 30, 60, 90, 120, 150, 180, 240, 300, 360, 420 and 480 minutes
7. C-peptide, measured at 0, 15, 30, 60, 90, 120, 150, 180, 240, 300, 360, 420 and 480 minutes
8. Gut hormones (including the incretin, glucose-dependent insulinotropic polypeptide, peptide YY and cholecystokinin), measured at 0, 15, 30, 60, 90, 120, 150, 180, 240, 300, 360, 420 and 480 minutes
9. Cytokines (interleukin-6, tumour necrosis factor alpha, E-selectin), measured at 0, 180, 240, 300 and 480 minutes
10. Factor VII activated concentrations, measured at 0, 180 and 360 minutes
Overall study start date20/02/2009
Completion date01/10/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants48 participants
Key inclusion criteriaHealthy males and females, aged 18 - 45 years.
Key exclusion criteria1. A reported history of heart disease, diabetes, cancer, kidney, liver or bowel disease (healthy volunteers are required)
2. Current cigarette smoker
3. History of substance abuse or alcoholism (previous weekly alcohol intake greater than 60 units/men or 50 units/women)
4. Current self-reported weekly alcohol intake exceeding 28 units
5. Unwilling to follow the protocol and/or give informed consent
6. Weight change of greater than 3 kg in preceding 2 months
7. Body mass index (BMI) less than 20 and greater than 35 kg/m^2
8. Blood pressure greater than 160/90 mmHg
9. Fasting blood cholesterol greater than 7.8 mmol/l, fasting plasma triacylglycerol concentrations greater than 3 mmol/l, or fasting plasma glucose greater than 7 mmol/L
10. Presence of gastrointestinal disorder or use of a drug, which is likely to alter gastrointestinal motility or nutrient absorption
11. Greater than or equal to 20% 10-year risk of cardiovascular disease (CVD) as calculated using the risk calculator
12. Vegetarian dietary practices
13. Pregnant women
Date of first enrolment20/02/2009
Date of final enrolment01/10/2009

Locations

Countries of recruitment

  • England
  • Netherlands
  • United Kingdom

Study participating centre

Nutritional Sciences Division
London
SE1 9NH
United Kingdom

Sponsor information

King's College London (UK)
University/education

Nutritional Sciences Division
Franklin Wilkins Building
150 Stamford St
London
SE1 9NH
England
United Kingdom

Website http://www.kcl.ac.uk
ROR logo "ROR" https://ror.org/0220mzb33

Funders

Funder type

Government

Malaysian Palm Oil Board (MPOB) (Malaysia)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2011 Yes No